134 related articles for article (PubMed ID: 15140233)
1. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.
Brown VL; Harwood CA; Crook T; Cronin JG; Kelsell DP; Proby CM
J Invest Dermatol; 2004 May; 122(5):1284-92. PubMed ID: 15140233
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of
Ren Y; Xiao L; Weng G; Shi B
Oncotarget; 2017 Sep; 8(38):64385-64394. PubMed ID: 28969078
[TBL] [Abstract][Full Text] [Related]
3. Nonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinoma.
Ben-Dayan MM; Ow TJ; Belbin TJ; Wetzler J; Smith RV; Childs G; Diergaarde B; Hayes DN; Grandis JR; Prystowsky MB; Schlecht NF
Cancer Med; 2017 Feb; 6(2):397-407. PubMed ID: 28102032
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia.
Volanakis EJ; Boothby MR; Sherr CJ
Exp Hematol; 2013 Apr; 41(4):377-86. PubMed ID: 23178376
[TBL] [Abstract][Full Text] [Related]
5. PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation.
Palanivel C; Madduri LSV; Hein AL; Jenkins CB; Graff BT; Camero AL; Zhou S; Enke CA; Ouellette MM; Yan Y
Aging (Albany NY); 2024 Mar; 16(5):4116-4137. PubMed ID: 38441530
[TBL] [Abstract][Full Text] [Related]
6. p16(Ink4a) inhibits histologic progression and angiogenic signaling in min colon tumors.
Gibson SL; Boquoi A; Chen T; Sharpless NE; Brensinger C; Enders GH
Cancer Biol Ther; 2005 Dec; 4(12):1389-94. PubMed ID: 16322687
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition.
Chan SH; Chiang J; Ngeow J
Hered Cancer Clin Pract; 2021 Mar; 19(1):21. PubMed ID: 33766116
[TBL] [Abstract][Full Text] [Related]
8. TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background.
Guijarro MV; Nawab A; Dib P; Burkett S; Luo X; Feely M; Nasri E; Seifert RP; Kaye FJ; Zajac-Kaye M
Oncogene; 2023 Jun; 42(23):1926-1939. PubMed ID: 37106126
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome.
Wong SL; Martiniuc D; Kiuru M
Clin Exp Dermatol; 2022 Dec; 47(12):2284-2285. PubMed ID: 35904890
[TBL] [Abstract][Full Text] [Related]
10. Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.
Li J; Poi MJ; Tsai MD
Biochemistry; 2011 Jun; 50(25):5566-82. PubMed ID: 21619050
[TBL] [Abstract][Full Text] [Related]
11. Loss of p14 diminishes immunogenicity in melanoma via non-canonical Wnt signaling by reducing the peptide surface density.
Wohlfarth J; Kosnopfel C; Faber D; Berthold M; Siedel C; Bernhardt M; Schlosser A; Aprati T; Liu D; Schrama D; Houben R; Schadendorf D; Goebeler M; Meierjohann S; Schilling B
Mol Oncol; 2024 May; ():. PubMed ID: 38807304
[TBL] [Abstract][Full Text] [Related]
12. Derivation of human primary prostate epithelial cell lines by differentially targeting the
Wasserman JS; Fowle H; Hashmi R; Atar D; Patel K; Yarmahmoodi A; Macfarlane AW; Tan Y; Cukierman E; Gligorijevic B; Karami A; Whelan KA; Campbell KS; Graña X
Res Sq; 2024 May; ():. PubMed ID: 38766032
[TBL] [Abstract][Full Text] [Related]
13. Transgenic and knockout mice models to reveal the functions of tumor suppressor genes.
Taneja P; Zhu S; Maglic D; Fry EA; Kendig RD; Inoue K
Clin Med Insights Oncol; 2011; 5():235-57. PubMed ID: 21836819
[TBL] [Abstract][Full Text] [Related]
14. Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype.
Zając A; Król SK; Rutkowski P; Czarnecka AM
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804155
[TBL] [Abstract][Full Text] [Related]
15. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression.
Ohtani N; Yamakoshi K; Takahashi A; Hara E
J Med Invest; 2004 Aug; 51(3-4):146-53. PubMed ID: 15460900
[TBL] [Abstract][Full Text] [Related]
16. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
Agrawal A; Yang J; Murphy RF; Agrawal DK
Exp Mol Pathol; 2006 Oct; 81(2):115-22. PubMed ID: 16919268
[TBL] [Abstract][Full Text] [Related]
18. Role of the p16 tumor suppressor gene in cancer.
Liggett WH; Sidransky D
J Clin Oncol; 1998 Mar; 16(3):1197-206. PubMed ID: 9508208
[TBL] [Abstract][Full Text] [Related]
19. p14ARF links the tumour suppressors RB and p53.
Bates S; Phillips AC; Clark PA; Stott F; Peters G; Ludwig RL; Vousden KH
Nature; 1998 Sep; 395(6698):124-5. PubMed ID: 9744267
[No Abstract] [Full Text] [Related]
20. Cellular mechanisms of tumour suppression by the retinoblastoma gene.
Burkhart DL; Sage J
Nat Rev Cancer; 2008 Sep; 8(9):671-82. PubMed ID: 18650841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
